Cabazitaxel in patients with refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Results of phase II trial unicancer ORL03.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cabazitaxel in patients with refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Results of phase II trial unicancer ORL03.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:e17028-e17028
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Fayette Jerome¹,Guigay Joel²,Le Tourneau Christophe³,Degardin Marian⁴,Peyrade Frederic⁵,Orlandini Florence⁶,Buffard Karine⁷,Bellera Carine A.⁸

Affiliation:

1. Centre Léon Bérard, Lyon, France

2. Gustave Roussy, Villejuif at present Centre Antoine-Lacassagne, IUFC, Nice, France

3. Department of Medical Oncology, Institut Curie, Paris, France

4. Centre Oscar Lambret, Lille, France

5. Anticancer Center, Centre Antoine-Lacassagne, IUFC, Nice, France

6. Centre Strauss, Strsbourg, France

7. H&N Unicancer Group, Paris, France

8. Institut Bergonié, Regional Comprehensive Cancer Center, Bordeaux, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.e17028

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A genetic view of laryngeal cancer heterogeneity;Cell Cycle;2016-03-03

2. Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs;HNO;2014-10-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP